XML 12 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Loss [Member]
Accumulated Other Comprehensive Income [Member]
Beginning Balance at Dec. 31, 2024 $ 757,500 $ 13,444 $ 1,298,160 $ (558,571) $ 4,467
Beginning Balance, shares at Dec. 31, 2024   108,064,340      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of Pre-Funded Warrants   $ 162 (162)    
Exercise of Pre-Funded Warrants,Shares   1,293,938      
Issuance of Earnout Shares 40,807 $ 226 40,581    
Issuance of Earnout Shares, shares   1,743,136      
Exercise of warrants 412 $ 2 410    
Exercise of warrants, shares   15,942      
Exercise of stock options 2,991 $ 116 2,875    
Exercise of stock options, shares   909,140      
Vesting of RSUs   $ 18 (18)    
Vesting of RSUs, shares   142,795      
Share-based compensation 15,213   15,213    
Total loss and comprehensive loss for the period (39,560)     (39,527) (33)
Ending Balance at Mar. 31, 2025 777,363 $ 13,968 1,357,059 (598,098) 4,434
Ending Balance, shares at Mar. 31, 2025   112,169,291      
Beginning Balance at Dec. 31, 2025 683,431 $ 14,278 1,426,750 (762,390) 4,793
Beginning Balance, shares at Dec. 31, 2025   114,399,326      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of warrants 1,753 $ 8 1,745    
Exercise of warrants, shares   56,619      
Exercise of stock options $ 11,049 $ 278 10,771    
Exercise of stock options, shares 1,971,548 1,971,548      
Vesting of RSUs   $ 30 (30)    
Vesting of RSUs, shares   214,163      
Share-based compensation $ 18,002   18,002    
Total loss and comprehensive loss for the period (49,013)     (48,441) (572)
Ending Balance at Mar. 31, 2026 $ 665,222 $ 14,594 $ 1,457,238 $ (810,831) $ 4,221
Ending Balance, shares at Mar. 31, 2026   116,641,656